Paper Details

Paper Title

Correction: <i>In Vivo</i> E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance Mechanisms.

Paper Journal Title

Cancer Discov

Paper Citation Count

Paper Publication Year

2018

Bio Mention

CDK4/6, E2F, MEK1/2, S6, mTOR

Mesh Descriptor

Column Actions